163 related articles for article (PubMed ID: 31305900)
41. High expression of CD26 accurately identifies human bacteria-reactive MR1-restricted MAIT cells.
Sharma PK; Wong EB; Napier RJ; Bishai WR; Ndung'u T; Kasprowicz VO; Lewinsohn DA; Lewinsohn DM; Gold MC
Immunology; 2015 Jul; 145(3):443-53. PubMed ID: 25752900
[TBL] [Abstract][Full Text] [Related]
42. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes.
Lanier LL; Chang C; Phillips JH
J Immunol; 1994 Sep; 153(6):2417-28. PubMed ID: 8077657
[TBL] [Abstract][Full Text] [Related]
43. Expression of S100 Protein in CD4-positive T-cell Lymphomas Is Often Associated With T-cell Prolymphocytic Leukemia.
Aggarwal N; Pongpruttipan T; Patel S; Bayerl MG; Alkan S; Nathwani B; Surti U; Kitahara S; Chinthammitr Y; Swerdlow SH
Am J Surg Pathol; 2015 Dec; 39(12):1679-87. PubMed ID: 26379148
[TBL] [Abstract][Full Text] [Related]
44. Analysis of stem-cell-like properties of human CD161++IL-18Rα+ memory CD8+ T cells.
Havenith SH; Yong SL; Henson SM; Piet B; Idu MM; Koch SD; Jonkers RE; Kragten NA; Akbar AN; van Lier RA; ten Berge IJ
Int Immunol; 2012 Oct; 24(10):625-36. PubMed ID: 22836020
[TBL] [Abstract][Full Text] [Related]
45. The possible role of CD8+/Vα7.2+/CD161++ T (MAIT) and CD8+/Vα7.2+/CD161
Meggyes M; Szanto J; Lajko A; Farkas B; Varnagy A; Tamas P; Hantosi E; Miko E; Szereday L
Am J Reprod Immunol; 2018 Feb; 79(2):. PubMed ID: 29265516
[TBL] [Abstract][Full Text] [Related]
46. T-cell prolymphocytic leukaemia: spontaneous immunophenotypical switch from CD4 to CD8 expression.
Tse E; So CC; Cheung WW; Kwong YL
Ann Hematol; 2011 Apr; 90(4):479-81. PubMed ID: 20625901
[No Abstract] [Full Text] [Related]
47. Increased frequency of CD4+ cells expressing CD161 in cancer patients.
Iliopoulou EG; Karamouzis MV; Missitzis I; Ardavanis A; Sotiriadou NN; Baxevanis CN; Rigatos G; Papamichail M; Perez SA
Clin Cancer Res; 2006 Dec; 12(23):6901-9. PubMed ID: 17145807
[TBL] [Abstract][Full Text] [Related]
48. Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression.
Nunes C; Wong R; Mason M; Fegan C; Man S; Pepper C
Clin Cancer Res; 2012 Feb; 18(3):678-87. PubMed ID: 22190592
[TBL] [Abstract][Full Text] [Related]
49. Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4.
Cosmi L; Maggi L; Santarlasci V; Capone M; Cardilicchia E; Frosali F; Querci V; Angeli R; Matucci A; Fambrini M; Liotta F; Parronchi P; Maggi E; Romagnani S; Annunziato F
J Allergy Clin Immunol; 2010 Jan; 125(1):222-30.e1-4. PubMed ID: 20109749
[TBL] [Abstract][Full Text] [Related]
50. A subset of virus-specific CD161
Alsuliman A; Muftuoglu M; Khoder A; Ahn YO; Basar R; Verneris MR; Muranski P; Barrett AJ; Liu E; Li L; Stringaris K; Armstrong-James D; Shaim H; Kondo K; Imahashi N; Andersson B; Marin D; Champlin RE; Shpall EJ; Rezvani K
Blood; 2017 Feb; 129(6):740-758. PubMed ID: 27821506
[TBL] [Abstract][Full Text] [Related]
51. CD4
Li C; Lu Z; Bi K; Wang K; Xu Y; Guo P; Chen Y; Zhou P; Wei Z; Jiang H; Cao Y
Reprod Biol Endocrinol; 2019 Oct; 17(1):78. PubMed ID: 31615517
[TBL] [Abstract][Full Text] [Related]
52. Phenotypic heterogeneity of persistent expansions of CD4+ CD8+ T cells.
Tonutti E; Sala P; Feruglio C; Yin Z; Colombatti A
Clin Immunol Immunopathol; 1994 Dec; 73(3):312-20. PubMed ID: 7955559
[TBL] [Abstract][Full Text] [Related]
53. NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells.
Slifka MK; Pagarigan RR; Whitton JL
J Immunol; 2000 Feb; 164(4):2009-15. PubMed ID: 10657652
[TBL] [Abstract][Full Text] [Related]
54. T-cell-mediated lysis of endothelial cells in acute coronary syndromes.
Nakajima T; Schulte S; Warrington KJ; Kopecky SL; Frye RL; Goronzy JJ; Weyand CM
Circulation; 2002 Feb; 105(5):570-5. PubMed ID: 11827921
[TBL] [Abstract][Full Text] [Related]
55. Peripheral blood CD161+ T cells from asthmatic patients are activated during asthma attack and predominantly produce IFN-gamma.
González-Hernández Y; Pedraza-Sánchez S; Blandón-Vijil V; del Río-Navarro BE; Vaughan G; Moreno-Lafont M; Escobar-Gutiérrez A
Scand J Immunol; 2007 Apr; 65(4):368-75. PubMed ID: 17386028
[TBL] [Abstract][Full Text] [Related]
56. CD147-mediated chemotaxis of CD4
Lv M; Miao J; Zhao P; Luo X; Han Q; Wu Z; Zhang K; Zhu P
Clin Rheumatol; 2018 Jan; 37(1):59-66. PubMed ID: 28948414
[TBL] [Abstract][Full Text] [Related]
57. [Clinical and Immunophenotypic Properties of Small Cell Variant of T-cell Prolymphocytic Leukemia].
Yu YP; Wang LP; Song P; Mei JG; An ZM; Zhou XG; Li F; Tang YM; Zhai YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):8-15. PubMed ID: 28245368
[TBL] [Abstract][Full Text] [Related]
58. CD8(+)NKR-P1A (+)T cells preferentially accumulate in human liver.
Ishihara S; Nieda M; Kitayama J; Osada T; Yabe T; Ishikawa Y; Nagawa H; Muto T; Juji T
Eur J Immunol; 1999 Aug; 29(8):2406-13. PubMed ID: 10458753
[TBL] [Abstract][Full Text] [Related]
59. Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functions.
Eger KA; Sundrud MS; Motsinger AA; Tseng M; Van Kaer L; Unutmaz D
PLoS One; 2006 Dec; 1(1):e50. PubMed ID: 17183680
[TBL] [Abstract][Full Text] [Related]
60. T-cell chronic lymphocytic leukemia or small-cell variant of T-cell prolymphocytic leukemia: a historical perspective and search for consensus.
Rashidi A; Fisher SI
Eur J Haematol; 2015 Sep; 95(3):199-210. PubMed ID: 25846234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
